Alector (ALEC) News Today $1.16 +0.05 (+4.50%) Closing price 04/23/2025 04:00 PM EasternExtended Trading$1.18 +0.02 (+1.64%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Alector, Inc. (NASDAQ:ALEC) Holdings Cut by JPMorgan Chase & Co.JPMorgan Chase & Co. reduced its stake in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 39.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,642,570 shares of the company's stockApril 23 at 3:22 AM | marketbeat.comAlector completes enrollment in PROGRESS-AD Phase 2 trial of AL01April 17, 2025 | markets.businessinsider.comAlector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer's DiseaseApril 17, 2025 | globenewswire.comContrasting Recursion Pharmaceuticals (NASDAQ:RXRX) and Alector (NASDAQ:ALEC)April 14, 2025 | americanbankingnews.comAlector, Inc. (NASDAQ:ALEC) Receives Consensus Recommendation of "Hold" from BrokeragesAlector, Inc. (NASDAQ:ALEC - Get Free Report) has received a consensus recommendation of "Hold" from the seven research firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and thrApril 1, 2025 | marketbeat.comAlector (NASDAQ:ALEC) Shares Down 3% - Here's WhyAlector (NASDAQ:ALEC) Shares Down 3% - Here's What HappenedMarch 30, 2025 | marketbeat.comAlector Names Giacomo Salvadore as Incoming Medical ChiefMarch 29, 2025 | marketwatch.comAlector Provides Executive Leadership UpdateMarch 28, 2025 | globenewswire.comAlector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection PointMarch 13, 2025 | seekingalpha.comAlector to Cut 13% of WorkforceMarch 10, 2025 | marketwatch.comMorgan Stanley Reaffirms Underweight Rating for Alector (NASDAQ:ALEC)Morgan Stanley reissued an "underweight" rating and issued a $1.50 target price (down previously from $3.00) on shares of Alector in a research note on Friday.March 8, 2025 | marketbeat.comAlector assumed with an Underweight at Morgan StanleyMarch 7, 2025 | markets.businessinsider.comAlector, Inc. (NASDAQ:ALEC) Given Consensus Recommendation of "Hold" by BrokeragesAlector, Inc. (NASDAQ:ALEC - Get Free Report) has been assigned a consensus recommendation of "Hold" from the seven analysts that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, two have given a hold recommendation and threMarch 6, 2025 | marketbeat.comFY2025 EPS Estimates for Alector Raised by Cantor FitzgeraldAlector, Inc. (NASDAQ:ALEC - Free Report) - Research analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for Alector in a report issued on Thursday, February 27th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the company will post earnings per shMarch 3, 2025 | marketbeat.comHC Wainwright Has Positive Estimate for Alector Q1 EarningsAlector, Inc. (NASDAQ:ALEC - Free Report) - Stock analysts at HC Wainwright increased their Q1 2025 earnings per share estimates for Alector in a research note issued to investors on Thursday, February 27th. HC Wainwright analyst A. Fein now expects that the company will post earnings per share oMarch 3, 2025 | marketbeat.comWilliam Blair Has Pessimistic Outlook of Alector Q1 EarningsAlector, Inc. (NASDAQ:ALEC - Free Report) - Equities research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for shares of Alector in a report released on Thursday, February 27th. William Blair analyst M. Minter now expects that the company will post earnings oMarch 3, 2025 | marketbeat.comFY2029 Earnings Forecast for Alector Issued By HC WainwrightAlector, Inc. (NASDAQ:ALEC - Free Report) - Research analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for shares of Alector in a research report issued to clients and investors on Thursday, February 27th. HC Wainwright analyst A. Fein forecasts that the company wilMarch 1, 2025 | marketbeat.comWhat is William Blair's Forecast for Alector Q1 Earnings?Alector, Inc. (NASDAQ:ALEC - Free Report) - Equities researchers at William Blair issued their Q1 2026 earnings per share (EPS) estimates for Alector in a research report issued on Thursday, February 27th. William Blair analyst M. Minter expects that the company will post earnings of ($0.54) perMarch 1, 2025 | marketbeat.comAlector Full Year 2024 Earnings: Beats ExpectationsFebruary 28, 2025 | uk.finance.yahoo.comAlector (NASDAQ:ALEC) Receives "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $7.00 price target on shares of Alector in a report on Thursday.February 28, 2025 | marketbeat.comQ4 2024 Alector Inc Earnings CallFebruary 27, 2025 | finance.yahoo.comAlector (NASDAQ:ALEC) Issues Quarterly Earnings Results, Beats Estimates By $0.59 EPSAlector (NASDAQ:ALEC - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.61) by $0.59. Alector had a negative net margin of 257.54% and a negative return on equity of 108.77%.February 27, 2025 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Alector (ALEC) and US Physical Therapy (USPH)February 27, 2025 | markets.businessinsider.comAlector, Inc. (ALEC) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | seekingalpha.comAlector’s 2024 Financial Results and Clinical AdvancementsFebruary 27, 2025 | tipranks.comAlector beats Q4 estimates, shares edge higherFebruary 26, 2025 | za.investing.comAlector Q4 2024 Earnings PreviewFebruary 26, 2025 | msn.comAlector reports Q4 EPS (2c), consensus (54c)February 26, 2025 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Alector (ALEC)February 26, 2025 | markets.businessinsider.comAlector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateFebruary 26, 2025 | globenewswire.comAlector Inc (ALEC) Q4 2024 Earnings Report Preview: What to ExpectFebruary 25, 2025 | finance.yahoo.comAlector to Participate in Upcoming Healthcare ConferencesFebruary 25, 2025 | globenewswire.comAlector to Host Fourth Quarter and Full-Year 2024 Earnings Conference CallFebruary 19, 2025 | globenewswire.comFebruary 2025 US Penny Stocks With Promising ProspectsFebruary 19, 2025 | finance.yahoo.comAlector (ALEC) to Release Quarterly Earnings on TuesdayAlector (NASDAQ:ALEC) will be releasing earnings before the market opens on Tuesday, February 25, Financial Modeling Prep reports.February 18, 2025 | marketbeat.comAlector, Inc. (NASDAQ:ALEC) Given Consensus Rating of "Hold" by BrokeragesShares of Alector, Inc. (NASDAQ:ALEC - Get Free Report) have received a consensus rating of "Hold" from the seven analysts that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, two have given a hold recommendation and threFebruary 9, 2025 | marketbeat.comAlector stock hits 52-week low at $1.59 amid market challengesFebruary 3, 2025 | msn.comAlector, Inc. (NASDAQ:ALEC) Sees Large Decrease in Short InterestAlector, Inc. (NASDAQ:ALEC - Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 5,170,000 shares, a decrease of 8.5% from the December 31st total of 5,650,000 shares. Based on an average trading volume of 1,250,000 shares, the days-to-cover ratio is presently 4.1 days. Approximately 6.8% of the company's shares are sold short.February 1, 2025 | marketbeat.comAlector’s Strategic Advancements and Promising Pipeline: A Buy Rating by Thomas ShraderJanuary 22, 2025 | markets.businessinsider.comAnalysts Offer Predictions for Alector FY2025 EarningsAlector, Inc. (NASDAQ:ALEC - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Alector in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst P. Stavropoulos anticipates that the company will earn ($2.55) per share for the yearJanuary 22, 2025 | marketbeat.comDiscovering 3 US Penny Stocks With Market Caps Below $200MJanuary 21, 2025 | finance.yahoo.comAlector, Inc. (NASDAQ:ALEC) Sees Large Drop in Short InterestAlector, Inc. (NASDAQ:ALEC - Get Free Report) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totalling 5,170,000 shares, a decline of 8.5% from the December 15th total of 5,650,000 shares. Approximately 6.8% of the company's stock are short sold. Based on an average daily trading volume, of 1,250,000 shares, the days-to-cover ratio is currently 4.1 days.January 18, 2025 | marketbeat.comBTIG Remains a Buy on Alector (ALEC)January 16, 2025 | markets.businessinsider.comWhy AbbVie Stock is on SaleJanuary 15, 2025 | baystreet.caAlector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Hold" from AnalystsShares of Alector, Inc. (NASDAQ:ALEC - Get Free Report) have received an average recommendation of "Hold" from the seven brokerages that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating and three haJanuary 15, 2025 | marketbeat.comAlector (ALEC) Receives a Sell from Bank of America SecuritiesJanuary 14, 2025 | markets.businessinsider.comSell Rating on Alector Due to Delays in Key Data Releases and Low Market CapJanuary 14, 2025 | markets.businessinsider.comAlector, Inc. Advances Neurodegeneration Pipeline with Key Clinical Trials and Strong Financial Position for 2025January 13, 2025 | quiverquant.comAlector Reports on Recent Progress and Outlines Strategic Priorities for 2025January 13, 2025 | globenewswire.comAlector, Inc. (NASDAQ:ALEC) Stake Raised by JPMorgan Chase & Co.JPMorgan Chase & Co. grew its holdings in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 64.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,728,823 shares of the company's stock afterJanuary 12, 2025 | marketbeat.com Get Alector News Delivered to You Automatically Sign up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter. Email Address ALEC Media Mentions By Week ALEC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALEC News Sentiment▼0.650.72▲Average Medical News Sentiment ALEC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALEC Articles This Week▼32▲ALEC Articles Average Week Get Alector News Delivered to You Automatically Sign up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Autolus Therapeutics News Eton Pharmaceuticals News Revance Therapeutics News Rapport Therapeutics News Amylyx Pharmaceuticals News Zevra Therapeutics News Mereo BioPharma Group News Altimmune News Kamada News Sana Biotechnology News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALEC) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alector, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alector With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALEC Stock Free ALEC Stock Alerts